Clinical Trial Update: Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine and liposomal doxorubicin in women with metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED